Continuous low-dose administration of parathyroid hormone or its agonist
US5747456A · kind A · utility
40Cited by
2References
21Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 30, 1996 |
| Grant date | May 5, 1998 |
| Priority date | — |
| Expiry date | Sep 30, 2016 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K14/635
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method of promoting bone formation in a human patient, which includes the step of administering continuously to the patient parathyroid hormone or its agonist for a period of at least one month at a dosage between 10 and 400 units/24 hrs. Also disclosed are novel parathyroid hormone agonists.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.